Pathway enrichment for the DEGs in carcinoma cell lines with low DMD expression suggested that DMD downregulation may affect the following KEGG pathways: ECM-receptor interaction (p = 0.037), protein digestion and absorption (p = 0.015), focal adhesion (p = 0.029), PI3K-Akt signaling (p = 0.021), cAMP signaling (p = 0.044), cGMP-PKG signaling (p = 0.024), and axon guidance (p = 0.002). This evidence concerns the gene DMD and carcinoma.